日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting FDFT1 Reduces Cholesterol and Bile Acid Production and Delays Hepatocellular Carcinoma Progression Through the HNF4A/ALDOB/AKT1 Axis.

靶向 FDFT1 可减少胆固醇和胆汁酸的产生,并通过 HNF4A/ALDOB/AKT1 轴延缓肝细胞癌的进展

Cai Dong, Zhong Guo-Chao, Dai Xin, Zhao Zhibo, Chen Menglin, Hu Jiejun, Wu Zhenru, Cheng Lve, Li Shengwei, Gong Jianping

Integrating bioinformatics and experimental validation to reveal a novel VRK score as a prognostic and therapeutic biomarker in hepatocellular carcinoma.

整合生物信息学和实验验证,揭示一种新的 VRK 评分作为肝细胞癌的预后和治疗生物标志物。

Fu Zhihao, Liu Dufei, Chen Menglin, Zhong Guochao, Zhao Zhibo, Gong Junhua, Dai Xin, Hu Jiejun, Jia Degong, Cheng Lve, Cai Dong, Gong Jianping

Association between CRP-TyG index and hepatic synthetic function in post-myocardial infarction ICU patients

心肌梗死后ICU患者CRP-TyG指数与肝脏合成功能的关系

Bao, Jiao; Hu, Jiejun; Lv, Xiangyin

Hybrid Blockchain for IoT-Energy Analysis and Reward Plan

用于物联网能源分析和奖励计划的混合区块链

Hu, Jiejun; Reed, Martin J; Al-Naday, Mays; Thomos, Nikolaos

Left-sided portal hypertension caused by peripancreatic lymph node tuberculosis misdiagnosed as pancreatic cancer: a case report and literature review

胰周淋巴结结核引起的左侧门静脉高压误诊为胰腺癌:病例报告及文献综述

Yu, Dajun; Li, Xiaolan; Gong, Jianping; Li, Jinzheng; Xie, Fei; Hu, Jiejun